3-CGMP
Current Good Manufacturing Practice (cGMP) and Good Compounding Practices
1. Overview of cGMP
Definition: System ensuring products are produced and controlled to quality standards.
Importance: Has the strongest impact on the industry, as it maintains product safety and efficacy.
Dynamic Nature: The term "current" emphasizes that GMP guidelines are continually evolving.
Shared Responsibility: Compliance is not solely the responsibility of Quality Control (QC); it also involves the production group.
2. Importance of cGMP
Risk Minimization: Objectives include reducing production risks such as contamination, incorrect labels, and dosage discrepancies.
Quality Assurance: Ensures products are:
Safe: Prevents harm to consumers.
Pure: Free from contaminants.
Effective: Achieves desired therapeutic effects.
3. Key Components of cGMP
3.1 Sections of cGMP
General Provisions
Organization and Personnel
Buildings and Facilities
Equipment
Control of Components and Drug Product Containers
Production and Process Control
Packaging and Labeling Controls
Holding and Distribution
Laboratory Controls
Records and Reports
Returned and Salvaged Drugs
3.2 Basic Requirements of GMP
Clearly defined and systematically reviewed processes.
Critical steps must be validated.
Appropriate resources allocated.
Clearly written procedures in place.
Comprehensive training and skill development of operators.
Complete records must be maintained.
Proper methods for storage and distribution.
Established recall systems and complaint handling procedures.
4. Organization and Personnel Responsibilities
Quality Control: Staff must have appropriate education and training; periodic health checks are essential.
Skill Development Programs: Must include continuing education and performance evaluations.
5. Facility and Equipment Standards
5.1 Buildings and Facilities
Must be designed for cleanliness, maintenance, and minimal congestion.
Adequate space and sanitation facilities are mandatory.
5.2 Equipment
Equipment must be suitable in design and size, facilitating operations and maintenance.
Standard Operating Procedures (SOPs) for equipment usage and maintenance.
Regular calibration and validation required to ensure effective operation.
6. Control of Components, Containers, and Closures
Documentation of written procedures is vital; specifications for physical and chemical properties must be met.
Raw materials must be quarantined and retested as needed; any rejected materials must be clearly identified.
7. Production and Process Controls
Detailed SOPs must be established; any production deviation must be documented and justified.
Continuous sampling and testing of materials and drug products are required.
8. Packaging and Labeling Control
Clear SOPs are needed for the handling and issuance of labeling and packaging materials.
Facilities must be inspected prior to labeling operations; all labels must comply with legal standards.
9. Record Keeping and Compliance
Detailed records (production, control, distribution) must be maintained for at least one year post expiration.
All records must be available for FDA inspection.
10. Current Good Compounding Practices
Need for Compounding: Addresses circumstances such as unavailability of specific dosages, allergies to certain excipients, and tailored patient needs (e.g., suitable doses for children).
Purpose: Compounding fulfills the requirements for patients with specific needs, including unique dosage forms and combinations.
11. Packaging, Labeling, and Stability
Packages must maintain the product's stability and protect against contamination.
Labeling must be clear, informative, and compliant with regulatory standards.
12. Storage and Expiration Considerations
Correct storage temperature is crucial; maintain conditions like:
Room temperature (20-25°C)
Refrigerated (2-8°C)
Freezer conditions (-25 to -10°C)
Consider expiration dating to guarantee efficacy and safety of the products.